Pinnacle Life Science Pvt. Ltd announced that it will issue 78,125 equity shares at an issue price of INR 1,280 per share( face value of INR 10 each will be allotted by Pinnacle at a premium of INR 1,270 per share) for the gross proceeds of INR 10,00,00,000 through rights issue on March 7, 2026. The transaction will include participation from returning investor Aarti Drugs Limited.

The transaction is expected to close on March 20, 2026.